In a groundbreaking decision, the U.S. International Trade Commission (USITC) has imposed an Apple watch ban. It impacts smartwatches in the United States, alleging the tech giant’s violation of a patent-related to biomarker technology.
The ruling, which came after a complaint by medical tech company Masimo, has far-reaching implications for Apple’s lucrative smartwatch business.
Tragic Mistake: Israeli Soldiers Accidentally Killed Three Hostages in Gaza City – USA Herald
HereAfter AI: Chatbots Communicate with Departed Loved Ones – USA Herald
Wonka Delights Audiences with a $39 Million Opening Weekend – USA Herald
Blue Origin Faces Setbacks on New Shepard Mission – USA Herald
The USITC Ruling
The USITC issued a limited exclusion order in October against Apple, responding to a patent infringement complaint lodged by Masimo. The order demanded that Apple “cease-and-desist” from importing and selling its Apple Watches equipped with pulse oximetry functionality, a move that could have significant consequences for the company’s revenue.
